Skip to content
Bayh-Dole at 45: Still an engine for innovation
A researcher working in a university lab makes a discovery that could lead to a new cure. Investors who see the potential of the […]
Bayh-Dole at 45: Still an engine for innovation Read More »
Health
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another transformative sector: health care
Charlotte emerging as a global leader in health care innovation and med tech Read More »
BIO-CSBA report explains why and how states seek to attract biotech
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are implementing policies designed to
BIO-CSBA report explains why and how states seek to attract biotech Read More »
Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation
When it comes to enabling new treatments for type 1 diabetes (T1D), Breakthrough T1D is an outstanding example of a patient group driving research
Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation Read More »
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely access to essential medicines,
Oncologist warns PBM step therapy has ‘crossed a dangerous line’ Read More »
BIO Coffee Chat: Guiding patients through Part D open enrollment
Medicare’s 2026 Open Enrollment period for Part D plans began on Oct. 15 and runs through Dec. 7. “As patient advocates have seen year
BIO Coffee Chat: Guiding patients through Part D open enrollment Read More »
BIO on the American Road: Indiana, a production powerhouse, is still expanding
At a time when the biopharma industry is seeking to increase U.S. manufacturing, Indiana is in the vanguard—and still expanding. During a Nov. 11
BIO on the American Road: Indiana, a production powerhouse, is still expanding Read More »
PACE: Downstream effects of IRA on patients
Three years after the passage of the Inflation Reduction Act (IRA), patient advocates and the biotech industry are working to navigate downstream negative impacts
PACE: Downstream effects of IRA on patients Read More »
PACE panel urges incentives for exciting new GTT drugs
Luke Rosen had hoped a new treatment would slow the progression of his daughter’s KIF1A Associated Neurological Disorder (KAND), but was amazed to see
PACE panel urges incentives for exciting new GTT drugs Read More »
PACE: How 340B outgrew its goal and stopped helping patients
The 340B program, in recent decades, has shown how the best laid plans can go sideways when not kept transparent and properly in check.
PACE: How 340B outgrew its goal and stopped helping patients Read More »